Arthur J. McCullough

Author

Also Known As

A Hofmann, A J McCullough, A McCullough, A Mccullough, A. Fialho, A. J. McCULLOUGH, A. J. McCullough, A. McCullough, A.J. McCullough, ARTHUR J. MCCULLOUGH

468

Publications

47.5K

Citations

H-Index

201

Concepts

All Affiliations

Cleveland Clinic Case Western Reserve University MetroHealth Medical Center Cleveland Clinic Lerner College of Medicine MetroHealth

About

Arthur J. McCullough is an author at Cleveland Clinic specializing in medicine, hepatology, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	49	99	23.8K
2	Health Sciences	35	54	18.8K
3	Public Health	6	6	688
4	Natural Sciences	4	4	235
5	Allergy	1	1	25

Arthur J. McCullough

198

Publications

39K

Citations

H-Index

Page 1

	Year	Citations
Design and validation of a histological scoring system for nonalcoholic fatty liver disease† David E. Kleiner, Elizabeth M. Brunt, Mark L. Van Natta, Hepatology Nafld Activity ScoreDiagnosisPathologyGastroenterologyFatty Liver Disease	2005	10.5K
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis Arun J. Sanyal, Naga Chalasani, Kris V. Kowdley, New England Journal of Medicine	2010	3.2K
Nonalcoholic Fatty Liver Disease Giulio Marchesini, Mara Brizi, Giampaolo Bianchi, Diabetes	2001	2.6K
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial Brent A. Neuschwander‐Tetri, Rohit Loomba, Arun J. Sanyal, The Lancet HepatologyMedicineLiver PhysiologyPathologyPlacebo-controlled Trial	2014	2.2K
Association of nonalcoholic fatty liver disease with insulin resistance Giulio Marchesini, Mara Brizi, Antonio Maria Morselli‐Labate, The American Journal of Medicine Insulin ResistanceObesityMetabolic SyndromeMetabolic Associated SteatohepatitisHepatology	1999	1.6K
Endpoints and clinical trial design for nonalcoholic steatohepatitis Arun J. Sanyal, Elizabeth M. Brunt, David E. Kleiner, Hepatology	2011	749
Long-Term Follow-Up of Patients With Nonalcoholic Fatty Liver Nila Rafiq, Chunhong Bai, Yun Fang, Clinical Gastroenterology and Hepatology ObesityMetabolic Associated SteatohepatitisHepatologyNonalcoholic Fatty Liver DiseaseMedicine	2008	733
Cytokeratin-18 Fragment Levels as Noninvasive Biomarkers for Nonalcoholic Steatohepatitis Ariel E. Feldstein, Anna Więckowska, Rocío López, Hepatology	2009	691
In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease Anna Więckowska, Nizar N. Zein, Lisa Yerian, Hepatology ApoptosisImmunologyPathologyCell DeathVivo Assessment	2006	669
Validity of real time ultrasound in the diagnosis of hepatic steatosis: A prospective study Srinivasan Dasarathy, Jaividhya Dasarathy, Amer Khiyami, Journal of Hepatology Medical UltrasoundHepatologyHealth SciencesAbdominal ImagingDiagnosis	2009	641

Page 1